BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2823455)

  • 41. Identification of immunologically distinct antigens in pseudorabies virus.
    Sun IL; Gustafson DP
    J Hyg Epidemiol Microbiol Immunol; 1982; 26(3):285-90. PubMed ID: 6183331
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Trial of vaccination against Aujeszky's disease].
    Motovski A; Veselinova A; Dobrev V
    Vet Med Nauki; 1980; 17(5):32-7. PubMed ID: 6262995
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Study of the symplast-forming activity of terpene and standard strains of Aujeszky's disease virus].
    Arnaudov Kh
    Vet Med Nauki; 1975; 12(1):36-44. PubMed ID: 174277
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Affinity-purified varicella-zoster virus glycoprotein gp1/gp3 stimulates the production of neutralizing antibody.
    Wroblewska Z; Gilden D; Green M; Devlin M; Vafai A
    J Gen Virol; 1985 Aug; 66 ( Pt 8)():1795-9. PubMed ID: 2991442
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Development of a production method of reproducing the Aujeszky's disease virus].
    Osidze DF; Fisenko SA; Khor'kov LA; Nochevnyĭ VT; Timakina KT
    Veterinariia; 1975 Oct; (10):39-42. PubMed ID: 174270
    [No Abstract]   [Full Text] [Related]  

  • 46. Excretion of specific glycoproteins by cells infected with herpes simplex virus, types 1 and 2.
    Kaplan AS; Erickson JS; Ben-Porat T
    Prog Med Virol; 1975; 21():1-12. PubMed ID: 54930
    [No Abstract]   [Full Text] [Related]  

  • 47. [Several features of Aujeszky disease virus].
    Veselinova A; Motovski A
    Vet Med Nauki; 1976; 13(7):9-15. PubMed ID: 189486
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Proteins specified by bovine herpesvirus type 4: structural proteins of the virion and identification of two major glycoproteins by using monoclonal antibodies.
    Dubuisson J; Boulanger D; Bublot M; Thiry E; Pastoret PP
    J Gen Virol; 1989 Jul; 70 ( Pt 7)():1743-53. PubMed ID: 2472465
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identification and isolation of the main component (gp350-gp220) of Epstein-Barr virus responsible for generating neutralizing antibodies in vivo.
    Thorley-Lawson DA; Poodry CA
    J Virol; 1982 Aug; 43(2):730-6. PubMed ID: 6287039
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Some characteristics of four attenuated vaccine virus strains and a virulent strain of Aujeszky's disease virus.
    van Oirschot JT; Gielkens AL
    Vet Q; 1984 Sep; 6(4):225-9. PubMed ID: 6093331
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Comparison of the biological properties of various strains of Aujeszky's disease viruses].
    Vecerka P
    Vet Med (Praha); 1987 Jan; 32(1):27-33. PubMed ID: 3031866
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Preparative isolation of purified antigens of the herpes simplex virus type I and a study of their immunogenic properties].
    Kliushnik SIu; Berezin VE; Novitskiĭ VA; Pushkarskaia NL; Zaĭdes VM
    Vopr Virusol; 1988; 33(1):48-51. PubMed ID: 2835870
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Differences in the polypeptide composition of virulent and avirulent strains of Newcastle disease virus in reproduction in chick embryo fibroblast culture].
    Vovk TS; Kaverin NV
    Vopr Virusol; 1978; (4):403-10. PubMed ID: 749337
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Biological properties of Junin virus proteins. I. Identification of the immunogenic glycoprotein.
    Cresta B; Padula P; de Martinez Segovia M
    Intervirology; 1980; 13(5):284-8. PubMed ID: 6250990
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pseudorabies virus (PRV) is protected from complement attack by cellular factors and glycoprotein C (gC).
    Maeda K; Hayashi S; Tanioka Y; Matsumoto Y; Otsuka H
    Virus Res; 2002 Mar; 84(1-2):79-87. PubMed ID: 11900841
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Incorporation of glycoproteins of the Aujeszky's disease virus ( Suid herpesvirus 1) into artificial liposome membranes and their interaction with cells].
    Vrublevskaia VV; Vinokurov MG; Kholodkov OA; Kornev AN; Morenkov OS
    Vopr Virusol; 2004; 49(2):32-6. PubMed ID: 15106382
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Preparation of ribonucleoproteins and virion envelopes of the Zaisan-260 and R-16225 strains of Semliki Forest virus antibody production].
    Krasnobaeva ZN; Mel'nikova EE; Gaĭdamovich SIa
    Vopr Virusol; 1977; (3):336-9. PubMed ID: 562032
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Comparative study of Aujeszky's disease virus reproduction in a suspension of poultry embryonic cells and tissues (author's transl)].
    Osidze DF; Fisenko SA; Khor'kov IA; Nochevnyĭ VT; Sokova VA
    Vopr Virusol; 1975; (5):581-6. PubMed ID: 1907
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lymphocytic choriomeningitis virus. VI. Isolation of a glycoprotein mediating neutralization.
    Bruns M; Cihak J; Müller G; Lehmann-Grube F
    Virology; 1983 Oct; 130(1):247-51. PubMed ID: 6636539
    [TBL] [Abstract][Full Text] [Related]  

  • 60. High level expression of soluble glycoproteins in the allantoic fluid of embryonated chicken eggs using a Sendai virus minigenome system.
    Corral T; Ver LS; Mottet G; Cano O; García-Barreno B; Calder LJ; Skehel JJ; Roux L; Melero JA
    BMC Biotechnol; 2007 Apr; 7():17. PubMed ID: 17411439
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.